132 related articles for article (PubMed ID: 12369980)
1. Origin of chiral pharmacology: stereochemistry in metalloprotease inhibition.
Kim DH
Mini Rev Med Chem; 2001 Jul; 1(2):155-61. PubMed ID: 12369980
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic insight into the inactivation of carboxypeptidase A by alpha-benzyl-2-oxo-1,3-oxazolidine-4-acetic acid, a novel type of irreversible inhibitor for carboxypeptidase A with no stereospecificity.
Chung SJ; Chung S; Lee HS; Kim EJ; Oh KS; Choi HS; Kim KS; Kim YJ; Hahn JH; Kim DH
J Org Chem; 2001 Sep; 66(19):6462-71. PubMed ID: 11559199
[TBL] [Abstract][Full Text] [Related]
3. Syntheses and kinetic evaluation of racemic and optically active 2-benzyl-2-methyl-3,4-epoxybutanoic acids as irreversible inactivators for carboxypeptidase A.
Lee M; Kim DH
Bioorg Med Chem; 2002 Apr; 10(4):913-22. PubMed ID: 11836098
[TBL] [Abstract][Full Text] [Related]
4. N-(Hydroxyaminocarbonyl)phenylalanine: a novel class of inhibitor for carboxypeptidase A.
Chung SJ; Kim DH
Bioorg Med Chem; 2001 Jan; 9(1):185-9. PubMed ID: 11197339
[TBL] [Abstract][Full Text] [Related]
5. Insight into the stereochemistry in the inhibition of carboxypeptidase A with N-(hydroxyaminocarbonyl)phenylalanine: binding modes of an enantiomeric pair of the inhibitor to carboxypeptidase A.
Cho JH; Kim DH; Chung SJ; Ha NC; Oh BH; Yong Choi K
Bioorg Med Chem; 2002 Jun; 10(6):2015-22. PubMed ID: 11937361
[TBL] [Abstract][Full Text] [Related]
6. Principles of hydroxamate inhibition of metalloproteases: carboxypeptidase A.
Mock WL; Cheng H
Biochemistry; 2000 Nov; 39(45):13945-52. PubMed ID: 11076537
[TBL] [Abstract][Full Text] [Related]
7. Sulfamide-based inhibitors for carboxypeptidase A. Novel type transition state analogue inhibitors for zinc proteases.
Park JD; Kim DH; Kim SJ; Woo JR; Ryu SE
J Med Chem; 2002 Nov; 45(24):5295-302. PubMed ID: 12431056
[TBL] [Abstract][Full Text] [Related]
8. A novel strategy for designing irreversible inhibitors of metalloproteases: acetals as latent electrophiles that interact with catalytic nucleophile at the active site.
Han MS; Ryu CH; Chung SJ; Kim DH
Org Lett; 2000 Oct; 2(20):3149-52. PubMed ID: 11009368
[TBL] [Abstract][Full Text] [Related]
9. 2-Benzyl-3,4-iminobutanoic acid as inhibitor of carboxypeptidase A.
Park JI; Kim DH
Bioorg Med Chem Lett; 2001 Nov; 11(22):2967-70. PubMed ID: 11677137
[TBL] [Abstract][Full Text] [Related]
10. Irreversible inhibition of zinc-containing protease by oxazolidinone derivatives. Novel inactivation chemistry.
Kim DH; Chung SJ; Kim EJ; Tian GR
Bioorg Med Chem Lett; 1998 Apr; 8(7):859-64. PubMed ID: 9871555
[TBL] [Abstract][Full Text] [Related]
11. Design of mechanism-based carboxypeptidase A inactivators on the basis of the X-ray crystal structure and catalytic reaction pathway.
Lee KJ; Kim DH
Bioorg Med Chem; 1998 Sep; 6(9):1613-22. PubMed ID: 9801832
[TBL] [Abstract][Full Text] [Related]
12. First hydroxamate inhibitors for carboxypeptidase A. N-acyl-N-hydroxy-beta-phenylalanines.
Kim DH; Jin Y
Bioorg Med Chem Lett; 1999 Mar; 9(5):691-6. PubMed ID: 10201830
[TBL] [Abstract][Full Text] [Related]
13. Nitro as a novel zinc-binding group in the inhibition of carboxypeptidase A.
Wang SH; Wang SF; Xuan W; Zeng ZH; Jin JY; Ma J; Tian GR
Bioorg Med Chem; 2008 Apr; 16(7):3596-601. PubMed ID: 18289863
[TBL] [Abstract][Full Text] [Related]
14. Cysteine derivatives as inhibitors for carboxypeptidase A: synthesis and structure-activity relationships.
Park JD; Kim DH
J Med Chem; 2002 Feb; 45(4):911-8. PubMed ID: 11831903
[TBL] [Abstract][Full Text] [Related]
15. Effect of zinc ion on the inhibition of carboxypeptidase A by imidazole-bearing substrate analogues.
Han MS; Kim DH
Bioorg Med Chem Lett; 2001 Jun; 11(11):1425-7. PubMed ID: 11378369
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of carboxypeptidase A complexed with D-cysteine at 1.75 A - inhibitor-induced conformational changes.
van Aalten DM; Chong CR; Joshua-Tor L
Biochemistry; 2000 Aug; 39(33):10082-9. PubMed ID: 10955996
[TBL] [Abstract][Full Text] [Related]
17. Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors.
Dublanchet AC; Ducrot P; Andrianjara C; O'Gara M; Morales R; Compère D; Denis A; Blais S; Cluzeau P; Courté K; Hamon J; Moreau F; Prunet ML; Tertre A
Bioorg Med Chem Lett; 2005 Aug; 15(16):3787-90. PubMed ID: 16002291
[TBL] [Abstract][Full Text] [Related]
18. A new inhibitor design strategy for carboxypeptidase A as exemplified by N-(2-chloroethyl)-N-methylphenylalanine.
Park JD; Lee KJ; Kim DH
Bioorg Med Chem; 2001 Feb; 9(2):237-43. PubMed ID: 11249116
[TBL] [Abstract][Full Text] [Related]
19. Stereoselective inhibition of glutamate carboxypeptidase by chiral phosphonothioic acids.
Lu H; Berkman CE
Bioorg Med Chem; 2001 Feb; 9(2):395-402. PubMed ID: 11249132
[TBL] [Abstract][Full Text] [Related]
20. A new type of carboxypeptidase A inhibitors designed using an imidazole as a zinc coordinating ligand.
Lee KJ; Joo KC; Kim EJ; Lee M; Kim DH
Bioorg Med Chem; 1997 Oct; 5(10):1989-98. PubMed ID: 9370042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
